Aberdeen Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.6M Sell
388,152
-32,635
-8% -$6.29M 0.12% 147
2025
Q4
$77.4M Buy
420,787
+20,678
+5% +$3.63M 0.12% 140
2025
Q3
$61.4M Buy
400,109
+2,317
+0.6% +$351K 0.1% 172
2025
Q2
$55.6M Buy
397,792
+7,896
+2% +$1.11M 0.09% 188
2025
Q1
$57.3M Sell
389,896
-310,849
-44% -$45M 0.11% 170
2024
Q4
$91.8M Buy
700,745
+19,587
+3% +$2.74M 0.17% 123
2024
Q3
$106M Sell
681,158
-72,104
-10% -$11.6M 0.19% 119
2024
Q2
$117M Buy
753,262
+5,224
+0.7% +$786K 0.23% 101
2024
Q1
$101M Buy
748,038
+37,600
+5% +$4.98M 0.2% 118
2023
Q4
$95.7M Buy
710,438
+551,245
+346% +$71.7M 0.21% 112
2023
Q3
$21.6M Buy
159,193
+800
+0.5% +$109K 0.06% 313
2023
Q2
$22.7M Sell
158,393
-500
-0.3% -$73.6K 0.05% 318
2023
Q1
$22.1M Buy
158,893
+10,450
+7% +$1.41M 0.06% 323
2022
Q4
$20.1M Hold
148,443
0.05% 331
2022
Q3
$16.3M Hold
148,443
0.05% 350
2022
Q2
$19.6M Sell
148,443
-14,855
-9% -$1.95M 0.06% 291
2022
Q1
$21.7M Sell
163,298
-19,400
-11% -$2.33M 0.06% 294
2021
Q4
$21.3M Sell
182,698
-15,250
-8% -$1.79M 0.05% 328
2021
Q3
$23.8M Buy
197,948
+12,320
+7% +$1.43M 0.05% 315
2021
Q2
$22.2M Buy
185,628
+5,650
+3% +$620K 0.05% 338
2021
Q1
$17.9M Buy
179,978
+600
+0.3% +$60.3K 0.04% 363
2020
Q4
$17.9M Buy
179,378
+44,528
+33% +$4.72M 0.04% 343
2020
Q3
$14.8M Sell
134,850
-900
-0.7% -$100K 0.04% 341
2020
Q2
$14.4M Hold
135,750
0.04% 345
2020
Q1
$12.1M Buy
+135,750
New +$12.8M 0.04% 358

Other funds holding AZN